RxDoctor Payments Data

Jamie Frederick

Family · Vincennes, INNPI 1629550165

Payments from drug & device makers

$837in general payments, 2019–2025

Across 58 payments — averaging $14.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$136
  • AbbVie$90
  • Novo Nordisk$85
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$84
  • AstraZeneca$59
  • Mylan Specialty L.p.$56
  • plus $327 from 13 others

What the payments were for

  • Food & beverage$837100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$837 in reported general payments places this provider in the 60th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$569
Medicare patients
13
Services billed
14

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide34$37,735
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$11,259
LinzessLinaclotide14$9,821
Albuterol Sulfate HfaAlbuterol Sulfate53$1,042
Gabapentin33$547
Pantoprazole Sodium34$452
Diclofenac Sodium25$382
Rosuvastatin Calcium34$373
Atorvastatin Calcium65$369
Ondansetron OdtOndansetron12$345
Omeprazole24$299
Levothyroxine Sodium35$287
Potassium Chloride17$265
Tamsulosin Hcl12$206
Duloxetine Hcl11$190

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$85$37,73534 claims
AstraZenecaBreztri Aerosphere$59$11,25913 claims
AbbVieLinzess$90$9,82114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,392 family providers in Indiana.

Other family in Vincennes

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →